Triplefin

triplefin.com

A market leader in patient support for more than 30 years, Triplefin delivers progressive hub services that improve patient access and adherence supported by its patent-pending Rx365® suite of digital solutions. Triplefin's programs help thousands of patients with serious diseases, offering hope and improved well-being.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

INDEGENE PARTNERS WITH AMWELL TO EMPOWER LIFE SCIENCES ORGANIZATIONS WITH UNPARALLELED PATIENT SUPPORT SOLUTIONS

Indegene Inc | June 29, 2022

news image

Indegene, a technology-led healthcare solutions provider, announced a partnership with Amwell®, a digital care delivery leader. This collaboration will facilitate life sciences organizations to connect patients to better quality care and drive better health outcomes. Digital patient engagement has disrupted the healthcare landscape. Patients are increasingly becoming more knowledgeable and involved in their health journeys. They want personalized support solutions that are ava...

Read More

Pharmacy Market

EIRION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT FOR HTL BIOTECHNOLOGY TO BECOME EIRION'S EXCLUSIVE BOTULINUM API MANUFACTURER

Eirion Therapeutics, Inc. | September 09, 2021

news image

Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnology solutions using hyaluronic acid and other biopolymers, will become Eirion's exclusive botulinum active pharmaceutical ingredient (API) manufacturer. Botulinum is the active ingredient in Eirion's lead product candidate ET-01, a topical neuromodulator being developed for Crow's Feet wrinkles and prima...

Read More

Business Insights

WITH VEEVA ECONSENT, CELERION IS CHANGING THE CONSENT EXPERIENCE FOR CLINICS AND PATIENTS

Veeva Systems | October 07, 2021

news image

Veeva Systems (NYSE: VEEV ) announced that Celerion has launched Veeva eConsent , a MyVeeva for Patients solution, to provide electronic consent for its Phase I clinical trials obtain. With Veeva eConsent, Celerion is moving from manual and paper-based consent forms to a fully digital process. The company uses Veeva eConsent for several studies and has already given their consent to more than 200 test subjects. Covid-19 limited the time we cou...

Read More

Business Insights, PHARMA TECH

KINDEVA AND MERIDIAN COMBINE: CREATE LEADING DRUG-DEVICE COMBINATION PRODUCT CDMO

Kindeva and | December 13, 2022

news image

Kindeva Drug Delivery and Meridian Medical Technologies announced the completion of the transaction to combine the two companies. The combination has created a leading global contract development and manufacturing organization focused on drug-device combination products. The combination will operate under the Kindeva name, with Meridian operating as, “Meridian Medical Technologies, a Kindeva Company”. The new Kindeva will have a broader range of drug delivery capabilit...

Read More
news image

Business Insights

INDEGENE PARTNERS WITH AMWELL TO EMPOWER LIFE SCIENCES ORGANIZATIONS WITH UNPARALLELED PATIENT SUPPORT SOLUTIONS

Indegene Inc | June 29, 2022

Indegene, a technology-led healthcare solutions provider, announced a partnership with Amwell®, a digital care delivery leader. This collaboration will facilitate life sciences organizations to connect patients to better quality care and drive better health outcomes. Digital patient engagement has disrupted the healthcare landscape. Patients are increasingly becoming more knowledgeable and involved in their health journeys. They want personalized support solutions that are ava...

Read More
news image

Pharmacy Market

EIRION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT FOR HTL BIOTECHNOLOGY TO BECOME EIRION'S EXCLUSIVE BOTULINUM API MANUFACTURER

Eirion Therapeutics, Inc. | September 09, 2021

Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnology solutions using hyaluronic acid and other biopolymers, will become Eirion's exclusive botulinum active pharmaceutical ingredient (API) manufacturer. Botulinum is the active ingredient in Eirion's lead product candidate ET-01, a topical neuromodulator being developed for Crow's Feet wrinkles and prima...

Read More
news image

Business Insights

WITH VEEVA ECONSENT, CELERION IS CHANGING THE CONSENT EXPERIENCE FOR CLINICS AND PATIENTS

Veeva Systems | October 07, 2021

Veeva Systems (NYSE: VEEV ) announced that Celerion has launched Veeva eConsent , a MyVeeva for Patients solution, to provide electronic consent for its Phase I clinical trials obtain. With Veeva eConsent, Celerion is moving from manual and paper-based consent forms to a fully digital process. The company uses Veeva eConsent for several studies and has already given their consent to more than 200 test subjects. Covid-19 limited the time we cou...

Read More
news image

Business Insights, PHARMA TECH

KINDEVA AND MERIDIAN COMBINE: CREATE LEADING DRUG-DEVICE COMBINATION PRODUCT CDMO

Kindeva and | December 13, 2022

Kindeva Drug Delivery and Meridian Medical Technologies announced the completion of the transaction to combine the two companies. The combination has created a leading global contract development and manufacturing organization focused on drug-device combination products. The combination will operate under the Kindeva name, with Meridian operating as, “Meridian Medical Technologies, a Kindeva Company”. The new Kindeva will have a broader range of drug delivery capabilit...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us